Repros Therapeutics, Inc. (RPRX) Posts Narrower than Expected Q3 Loss
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $57.16 -0.82%
Financial Fact:
Research and development: 3.18M
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Research and development: 3.18M
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q3 loss of ($0.32), $0.03 better than the analyst estimate of ($0.35).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
- FactSet (FDS) Tops Q4 EPS by 17c, Beats on Revenue; Offers FY Guidance
- Carnival Corp. (CCL) Tops Q3 EPS by 8c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
